BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 28429185)

  • 41. The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity.
    Amacher DE
    Toxicol Appl Pharmacol; 2010 May; 245(1):134-42. PubMed ID: 20219512
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tomorrow today: organ-on-a-chip advances towards clinically relevant pharmaceutical and medical in vitro models.
    Rothbauer M; Rosser JM; Zirath H; Ertl P
    Curr Opin Biotechnol; 2019 Feb; 55():81-86. PubMed ID: 30189349
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Organs-on-a-Chip.
    Low LA; Sutherland M; Lumelsky N; Selimovic S; Lundberg MS; Tagle DA
    Adv Exp Med Biol; 2020; 1230():27-42. PubMed ID: 32285363
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cell-Based Assays on Microfluidics for Drug Screening.
    Liu X; Zheng W; Jiang X
    ACS Sens; 2019 Jun; 4(6):1465-1475. PubMed ID: 31074263
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Emerging trends in organ-on-a-chip systems for drug screening.
    Wang Y; Gao Y; Pan Y; Zhou D; Liu Y; Yin Y; Yang J; Wang Y; Song Y
    Acta Pharm Sin B; 2023 Jun; 13(6):2483-2509. PubMed ID: 37425038
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sensors in heart-on-a-chip: A review on recent progress.
    Cho KW; Lee WH; Kim BS; Kim DH
    Talanta; 2020 Nov; 219():121269. PubMed ID: 32887159
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lung-on-a-chip: the future of respiratory disease models and pharmacological studies.
    Shrestha J; Razavi Bazaz S; Aboulkheyr Es H; Yaghobian Azari D; Thierry B; Ebrahimi Warkiani M; Ghadiri M
    Crit Rev Biotechnol; 2020 Mar; 40(2):213-230. PubMed ID: 31906727
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Integrated human organ-on-a-chip model for predictive studies of anti-tumor drug efficacy and cardiac safety.
    Chramiec A; Teles D; Yeager K; Marturano-Kruik A; Pak J; Chen T; Hao L; Wang M; Lock R; Tavakol DN; Lee MB; Kim J; Ronaldson-Bouchard K; Vunjak-Novakovic G
    Lab Chip; 2020 Nov; 20(23):4357-4372. PubMed ID: 32955072
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current Strategies and Future Perspectives of Skin-on-a-Chip Platforms: Innovations, Technical Challenges and Commercial Outlook.
    Bal-Öztürk A; Miccoli B; Avci-Adali M; Mogtader F; Sharifi F; Çeçen B; Yaşayan G; Braeken D; Alarcin E
    Curr Pharm Des; 2018; 24(45):5437-5457. PubMed ID: 30727878
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lung on a Chip for Drug Screening and Design.
    Kızılkurtlu AA; Polat T; Aydın GB; Akpek A
    Curr Pharm Des; 2018; 24(45):5386-5396. PubMed ID: 30734673
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Step-by-step fabrication of heart-on-chip systems as models for cardiac disease modeling and drug screening.
    Deir S; Mozhdehbakhsh Mofrad Y; Mashayekhan S; Shamloo A; Mansoori-Kermani A
    Talanta; 2024 Jan; 266(Pt 1):124901. PubMed ID: 37459786
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recent Advances in Body-on-a-Chip Systems.
    Sung JH; Wang YI; Narasimhan Sriram N; Jackson M; Long C; Hickman JJ; Shuler ML
    Anal Chem; 2019 Jan; 91(1):330-351. PubMed ID: 30472828
    [No Abstract]   [Full Text] [Related]  

  • 53. User-Friendly and Parallelized Generation of Human Induced Pluripotent Stem Cell-Derived Microtissues in a Centrifugal Heart-on-a-Chip.
    Schneider O; Zeifang L; Fuchs S; Sailer C; Loskill P
    Tissue Eng Part A; 2019 May; 25(9-10):786-798. PubMed ID: 30968738
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Brain-on-a-chip Devices for Drug Screening and Disease Modeling Applications.
    Miccoli B; Braeken D; Li YE
    Curr Pharm Des; 2018; 24(45):5419-5436. PubMed ID: 30806304
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Microphysiological Systems (Tissue Chips) and their Utility for Rare Disease Research.
    Low LA; Tagle DA
    Adv Exp Med Biol; 2017; 1031():405-415. PubMed ID: 29214585
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chips for Biomaterials and Biomaterials for Chips: Recent Advances at the Interface between Microfabrication and Biomaterials Research.
    Guttenplan APM; Tahmasebi Birgani Z; Giselbrecht S; Truckenmüller RK; Habibović P
    Adv Healthc Mater; 2021 Jul; 10(14):e2100371. PubMed ID: 34033239
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preclinical approaches to assess potential kinase inhibitor-induced cardiac toxicity: Past, present and future.
    Yang B; Papoian T
    J Appl Toxicol; 2018 Jun; 38(6):790-800. PubMed ID: 29369373
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Construction of a liver sinusoid based on the laminar flow on chip and self-assembly of endothelial cells.
    Mi S; Yi X; Du Z; Xu Y; Sun W
    Biofabrication; 2018 Feb; 10(2):025010. PubMed ID: 29460846
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Organ-On-A-Chip: A Survey of Technical Results and Problems.
    Danku AE; Dulf EH; Braicu C; Jurj A; Berindan-Neagoe I
    Front Bioeng Biotechnol; 2022; 10():840674. PubMed ID: 35223800
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Approaching the in vitro clinical trial: engineering organs on chips.
    Capulli AK; Tian K; Mehandru N; Bukhta A; Choudhury SF; Suchyta M; Parker KK
    Lab Chip; 2014 Sep; 14(17):3181-6. PubMed ID: 24828385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.